TransCode Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$18,546,095 over the previous period. Total operating expenses were $19,418,516.
Profit Margin
| 2019 | 0 | -764.14K | |
|---|---|---|---|
| 2020 | 0 | -2.73M | |
| 2021 | 0 | -6.93M | |
| 2022 | 0 | -35.12M | |
| 2023 | 0 | -18.54M |
RNAZ Income Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Revenue | |||||
Revenue | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 516.74K | 98.60K | 42.47K | 0 | 0 |
Gross profit | -516.74K | -98.60K | -42.47K | 0 | 0 |
Operating exp. | |||||
Research and development | 12.26M | 10.23M | 2.75M | 284.45K | 226.30K |
Selling and marketing | -7.14B | 0 | 0 | 0 | 0 |
Total operating expenses | 19.41M | 17.58M | 5.87M | 726.60K | 456.86K |
Operating income | -19.41M | -18.66M | -6.15M | -726.60K | -456.86K |
Other income (expenses), net | 872.42K | 1.10M | -692.26K | -1.61M | -150.34K |
Income before tax | -18.54M | -17.56M | -6.84M | -2.34M | -607.21K |
Income tax expense | 0 | 17.56M | 95.07K | 394.43K | 156.93K |
Net income | -18.54M | -35.12M | -6.93M | -2.73M | -764.14K |
Earnings per share | |||||
Basic EPS | -103.61 | -2.19K | -658.8 | -343.19 | -119.27 |
Diluted EPS | -103.61 | -2.16K | -658.8 | -343.19 | -119.27 |
| Data source | Data source | Data source |